Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure

Circulation: Heart Failure

Volumn 3, Issue 3, 2010, Pages 420-430

  Kato, Takao ^a   Niizuma, Shinichiro ^a   Inuzuka, Yasutaka ^a   Kawashima, Tsuneaki ^a   Okuda, Junji ^a   Tamaki, Yodo ^a   Iwanaga, Yoshitaka ^a   Narazaki, Michiko ^a   Matsuda, Tetsuya ^a   Soga, Tomoyoshi ^b   Kita, Toru ^a   Kimura, Takeshi ^a   Shioi, Tetsuo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Dichloroacetate; Glycolysis; Heart failure; Hypertrophy; Pentose phosphate pathway

Indexed keywords

DICHLOROACETIC ACID; FATTY ACID; GLUCOSE; PENTOSE PHOSPHATE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DISEASE COURSE; ENERGY METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GENE EXPRESSION; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HIGH SODIUM INTAKE; MALE; METABOLOME; MITOCHONDRION; NONHUMAN; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; RAT; REDOX STRESS; SURVIVAL; ANIMAL; DISEASE MODEL; HEART FAILURE; METABOLISM; PHYSIOLOGY;

ANIMALS; DICHLOROACETATE; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FATTY ACIDS; GLUCOSE; HEART FAILURE; HYPERTROPHY, LEFT VENTRICULAR; MALE; METABOLOME; RATS; RATS, INBRED DAHL; VENTRICULAR REMODELING;

EID: 77954743140     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.109.888479     Document Type: Article

References (30)

1. Hampl V, Bibova J, Povysilova V, Herget J: Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats. Eur Respir J. 2003;21:862-865. (Pubitemid 36592298)
2. Inoko M, Kihara Y, Morii I, Fujiwara H, Sasayama S. Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. Am J Physiol. 1994;267:2471-2482.
3. Shioi T, McMullen JR, Tarnavski O, Converso K, Sherwood MC, Manning,WJ, Izumo S. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation. 2003;107:1664-1670.
4. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clinical Biochemistry. 1996;29:255-1229
5. Bottomley PA. Noninvasive study of high-energy phosphate metabolism in human heart by depth-resolved 31P NMR spectroscopy. Science. 1985;229:769-772.
6. Fujii N, Nozawa T, Igawa A, Kato B, Igarashi N, Nonomura M, Asanoi H, Tazawa S, Inoue M, Inoue H. Saturated glucose uptake capacity and impaired fatty acid oxidation in hypertensive hearts before development of heart failure. Am J Physiol Hear Circ Physiol. 2004;287:H760-766.
7. Soga T, Ohashi Y, Ueno Y, Naraoka H, Tomita M, Nishioka T. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J Proteome Res. 2003;2:488-494.
8. Iwanaga Y, Hoshijima M, Gu Y, Iwatate M, Dieterle T, Ikeda Y, Date MO, Chras J, Matsuzaki M, Peterson KL, Chien KR, Ross JJr. Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats. J Clin Invest. 2004;113:727-736.
9. Kondoh H, Lleonart ME, Gil J. Wang J, Degan P, Peters G, Martinez D, Carnero A, Beach D. Glycolytic enzymes can modulate cellular life span. Cancer Res. 2005;65:177-185.
10. Tsutsumi S, Yanagawa T, Shimura T, Fukumori T, Hogan V, Kuwano H, Raz A. Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling. J Biol Chem. 2003;278:32165-32172.
11. Hasegawa K, Meyers MB, Kitsis RN. Transcriptional coactivator p300 stimulates cell type-specific gene expression in cardiac myocytes. J Biol Chem. 1997;272:20049-20054.
12. Jain M, Brenner DA, Cui L, Lim CC, Wang B, Pimentel DR, Koh S, Sawyer DB, Leopold JA, Handy DE, Loscalzo J, Apstein CS, Liao R. Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes. Circ Res. 2003;93:e9-16.
13. Gupte SA, Arshad M, Viola S, Kaminski PM, Ungvari Z, Rabbani G, Koller A, Wolin MS. Pentose phosphate pathway coordinates multiple redox-controlled relaxing mechanisms in bovine coronary arteries. Am J Physiol Heart Circ Physiol. 2003;285:H2316-2326.
14. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1 and SIRT1. Nature. 2005;434:113-118.
15. Gao L, Mejías R, Echevarría M, Löpez-Barneo J. Induction of the glucose-6-phosphate dehydrogenase gene expression by chronic hypoxia in PC12 cells. FEBS Lett. 2004;569:256-260.
16. McAinch AJ, Lee JS, Bruce CR, Tunstall RJ, Hawley JA, Cameron-Smith D. Dietary regulation of fat oxidative gene expression in different skeletal muscle fiber types. Obes Res. 2003;11:1471-1479.
17. Ota M, Mori K, Nakashima A, Kaneko YS, Takahashi H, Ota A. Resistance to excessive bodyweight gain in risperidone-injected rats. Clin Exp Pharmacol Physiol. 2005;32:279-287.
18. Zoll J, Monassier L, Garnier A, N'Guessan B, Mettauer B, Veksler V, Piquard F, Ventura-Clapier R, Geny B. ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction. J Appl Physiol. 2006;101:385-391.
19. Garnier A, Fortin D, Deloménie C, Momken I, Veksler V, Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol. 2003;551:491-501.
20. Tam NN, Gao Y, Leung YK, Ho SM. Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth. Am J Pathol. 2003; 163:2513-2522.
21. Scott DK, Collier JJ, Doan TT, Bunnell AS, Daniels MC, Eckert DT, O'Doherty RM. A modest glucokinase overexpression in the liver promotes fed expression levels of glycolytic and lipogenic enzyme genes in the fasted state without altering SREBP-1c expression. Mol Cell Biochem. 2003;254:327-337.
22. García-Delgado M, García-Miranda P, Peral MJ, Calonge ML, Ilundáin AA. Ontogeny up-regulates renal Na(+)/Cl(-)/creatine transporter in rat. Biochim Biophys Acta. 2007;1768:2841-2848.
23. Neubauer S, Frank M, Hu K, Remkes H, Laser A, Horn M, Ertl G, Lohse MJ. Changes of creatine kinase gene expression in rat heart post-myocardial infarction. J Mol Cell Cardiol. 1998;30:803-810.
24. Louhelainen M, Vahtola E, Kaheinen P, Leskinen H, Merasto S, Kytö V, Finckenberg P, Colucci WS, Levijoki J, Pollesello P, Haikala H, Mervaala EM. Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats. Br J Pharmacol. 2007;150:851-861.
25. Mudge GH, Mills RM, Taegtmeyer H, Gorlin R, Lesch M. Alterations of myocardial amino acid metabolism in chronic ischemic heart disease. J Clin Invest. 1976;58:1185-1192.
26. Nakamura H, Yatsuki J, Ubuka T. Production of hypotaurine, taurine and sulfate in rats and mice injected with L-cysteinesulfinate. Amino Acids. 2006;31:27-33.
27. Kaye DM, Parnell MM, Ahlers BA. Reduced myocardial and systemic L-arginine uptake in heart failure. Circ Res. 2002;91:1198-1203.
28. Turer AT, Stevens RD, Bain JR, Muehlbauer MJ, van der Westhuizen J, Mathew JP, Schwinn DA, Glower DD, Newgard CB, Podgoreanu MV. Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. Circulation. 2009;119:1736-1746.
29. Pasini E, Aquilani R, Dioguardi FS, D'Antona G, Gheorghiade M, Taegtmeyer H. Hypercatabolic syndrome: molecular basis and effects of nutritional supplements with amino acids. Am J Cardiol. 2008;101:11-15.
30. Rector TS, Bank AJ, Mullen KA, Tschumperlin LK, Sih R, Pillai K, Kubo SH. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation. 1996;93:2135-2141